BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas